valine has been researched along with Mood Disorders in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (33.33) | 29.6817 |
2010's | 11 (61.11) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Kremens, DE; McEvoy, JP | 1 |
Burke, J; Factor, SA; Hauser, RA; Jimenez, R; Knesevich, MA; Liang, GS; Marder, SR; O'Brien, CF; Ramirez, PM | 1 |
George Priya Doss, C; Kajal, K; Magesh, R; Saini, S; Siva, R; Sneha, P; Thirumal Kumar, D | 1 |
Burke, J; Correll, CU; Josiassen, RC; Liang, GS; O'Brien, CF | 1 |
Burke, J; Josiassen, RC; Kane, JM; Liang, GS; O'Brien, CF | 1 |
Burke, J; Calabrese, JR; Farahmand, K; McIntyre, RS; Nierenberg, AA; Siegert, S; Yonan, C | 1 |
Correll, CU; Cutler, AJ; Kane, JM; Liang, GS; O'Brien, CF; Sajatovic, M; Stacy, M | 1 |
Arrigo, R; Bruno, A; Caccamo, D; Currò, M; Gangemi, C; Gugliandolo, A; La Ciura, G; Muscatello, MR; Pandolfo, G; Zoccali, R | 1 |
Amouzadeh-Ghadikolai, O; Baranyi, A; Hlade, P; Mangge, H; Meinitzer, A; Reicht, G; Robier, C; Rothenhäusler, HB; Theokas, S; von Lewinski, D | 1 |
Feng, X; Jia, J; Wang, W; Xie, Y; Zhang, G | 1 |
Burdick, KE; DeRosse, P; Kane, JM; Lencz, T; Lipsky, RH; Malhotra, AK | 1 |
Arias-Vásquez, A; Fernández, G; Franke, B; Gerritsen, L; Rijpkema, M; Tendolkar, I; van Oostrom, I | 1 |
Bucci, DJ; Davis, FC; Hopkins, ME; Vantieghem, MR; Whalen, PJ | 1 |
Hong, CJ; Huo, SJ; Pan, GM; Tsai, SJ; Tung, CL; Yen, FC | 1 |
Barr, CL; George, CJ; Kennedy, JL; King, N; Kovacs, M; Ryan, CM; Shaikh, S; Strauss, J | 1 |
Enoch, MA; Harris, CR; Hoberman, J; Jiang, X; Lipsky, RH; Marini, AM; Marko, AJ; Tian, F; Waheed, JF; Xu, K | 1 |
Jun, TY; Kim, JJ; Lee, C; Pae, CU; Paik, IH; Patkar, A; Yoon, SJ | 1 |
Aguilera, M; Delespaul, P; Derom, C; Jacobs, N; Kenis, G; Krabbendam, L; Mengelers, R; Myin-Germeys, I; Peeters, F; van Os, J; Vlietinck, R; Wichers, M | 1 |
5 trial(s) available for valine and Mood Disorders
Article | Year |
---|---|
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
Topics: Abnormal Involuntary Movement Scale; Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Treatment Outcome; Valine | 2017 |
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2017 |
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Long Term Adverse Effects; Male; Middle Aged; Mood Disorders; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2017 |
The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder.
Topics: Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Tardive Dyskinesia; Tetrabenazine; Valine | 2019 |
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference.
Topics: Aged; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Minimal Clinically Important Difference; Mood Disorders; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Treatment Outcome; Valine; Vesicular Monoamine Transport Proteins | 2019 |
13 other study(ies) available for valine and Mood Disorders
Article | Year |
---|---|
Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia.
Topics: Antipsychotic Agents; Diagnosis, Differential; Drug Monitoring; Early Diagnosis; Humans; Membrane Transport Modulators; Mood Disorders; Patient Care; Patient Education as Topic; Psychology; Risk Assessment; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine | 2020 |
Analyzing the Effect of V66M Mutation in BDNF in Causing Mood Disorders: A Computational Approach.
Topics: Amino Acid Sequence; Brain-Derived Neurotrophic Factor; Conserved Sequence; Humans; Methionine; Molecular Dynamics Simulation; Mood Disorders; Point Mutation; Protein Interaction Maps; Protein Structure, Secondary; Valine | 2017 |
Association of the COMT synonymous polymorphism Leu136Leu and missense variant Val158Met with mood disorders.
Topics: Alleles; Analysis of Variance; Bipolar Disorder; Catechol O-Methyltransferase; Depressive Disorder, Major; Female; Humans; Leucine; Male; Methionine; Middle Aged; Mood Disorders; Mutation, Missense; Polymorphism, Genetic; Valine | 2015 |
Branched-Chain Amino Acids as New Biomarkers of Major Depression - A Novel Neurobiology of Mood Disorder.
Topics: Adult; Amino Acids, Branched-Chain; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Down-Regulation; Energy Metabolism; Female; Humans; Isoleucine; Leucine; Male; Middle Aged; Mood Disorders; Nervous System; TOR Serine-Threonine Kinases; Valine | 2016 |
Clinical characterization of an APP mutation (V717I) in five Han Chinese families with early-onset Alzheimer's disease.
Topics: Age of Onset; Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Apolipoprotein E4; Asian People; Cognition Disorders; DNA Mutational Analysis; Family Health; Female; Humans; Isoleucine; Magnetic Resonance Imaging; Male; Middle Aged; Mood Disorders; Mutation; Neuropsychological Tests; Valine | 2017 |
Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes.
Topics: Adult; Alleles; Brain-Derived Neurotrophic Factor; Case-Control Studies; Female; Genetic Markers; Genotype; Haplotypes; Humans; Male; Mood Disorders; Polymorphism, Genetic; Schizophrenia; Valine | 2009 |
Interaction between BDNF Val66Met and childhood stressful life events is associated to affective memory bias in men but not women.
Topics: Adolescent; Adult; Bias; Brain-Derived Neurotrophic Factor; Female; Genetic Association Studies; Genotype; Humans; Life Change Events; Male; Mental Recall; Methionine; Mood Disorders; Polymorphism, Genetic; Psychiatric Status Rating Scales; Sex Factors; Surveys and Questionnaires; Valine; Young Adult | 2012 |
Differential effects of acute and regular physical exercise on cognition and affect.
Topics: Activities of Daily Living; Adolescent; Adult; Affect; Brain-Derived Neurotrophic Factor; Cognition; Exercise; Genetic Testing; Humans; Methionine; Mood Disorders; Neuropsychological Tests; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Recognition, Psychology; Stress, Psychological; Valine; Young Adult | 2012 |
Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior.
Topics: Adult; Age of Onset; Aged; Brain-Derived Neurotrophic Factor; Case-Control Studies; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Methionine; Middle Aged; Mood Disorders; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis; Suicide; Valine | 2003 |
BDNF and COMT polymorphisms: relation to memory phenotypes in young adults with childhood-onset mood disorder.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Brain; Brain Chemistry; Brain-Derived Neurotrophic Factor; Catechol O-Methyltransferase; Child; Dopamine; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Intelligence; Male; Memory; Methionine; Mood Disorders; Phenotype; Polymorphism, Genetic; Sex Factors; Valine | 2004 |
BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects.
Topics: Adult; Amino Acid Substitution; Animals; Anxiety; Brain-Derived Neurotrophic Factor; Cells, Cultured; Diagnostic and Statistical Manual of Mental Disorders; Electrophoretic Mobility Shift Assay; Embryo, Mammalian; Female; Gene Frequency; Genetic Variation; Genotype; Hippocampus; Humans; Male; Methionine; Middle Aged; Mood Disorders; Neurons; Personality Inventory; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection; Valine | 2005 |
Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism and mood disorders: a preliminary study.
Topics: Adult; Alanine; Chi-Square Distribution; DNA Mutational Analysis; Female; Humans; Male; Middle Aged; Mood Disorders; Polymorphism, Genetic; Superoxide Dismutase; Valine | 2006 |
The catechol-O-methyl transferase Val158Met polymorphism and experience of reward in the flow of daily life.
Topics: Adaptation, Psychological; Adolescent; Adult; Affect; Amino Acid Substitution; Brain; Brain Chemistry; Catechol O-Methyltransferase; Depressive Disorder; Dopamine; Female; Humans; Male; Methionine; Middle Aged; Mood Disorders; Polymorphism, Genetic; Reward; Substance-Related Disorders; Valine; Young Adult | 2008 |